Qingdao Haier Biomedical Co Ltd (688139) — Free Cash Flow Generation Index
Qingdao Haier Biomedical Co Ltd (688139) has a Free Cash Flow Generation Index of -6.36x as of June 2023. Free cash flow of CN¥-46.60 Million represents -6% of operating cash flow (CN¥7.33 Million). Read 688139 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Qingdao Haier Biomedical Co Ltd Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Qingdao Haier Biomedical Co Ltd across 10 annual periods. Explore how much does Qingdao Haier Biomedical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year Free Cash Flow Generation Index for Qingdao Haier Biomedical Co Ltd. For the full company profile including market capitalisation, see 688139 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | CN¥148.64 Million | CN¥267.89 Million | CN¥119.25 Million | ▼ -1.9% |
| 2024 | 0.57x | CN¥164.96 Million | CN¥291.67 Million | CN¥126.70 Million | ▲ +95.6% |
| 2023 | 0.29x | CN¥72.08 Million | CN¥249.26 Million | CN¥177.18 Million | ▼ -45.9% |
| 2022 | 0.53x | CN¥338.18 Million | CN¥632.43 Million | CN¥294.24 Million | ▼ -12.6% |
| 2021 | 0.61x | CN¥387.11 Million | CN¥632.43 Million | CN¥204.69 Million | ▼ -29.8% |
| 2020 | 0.87x | CN¥607.63 Million | CN¥696.62 Million | CN¥88.99 Million | ▲ +118.3% |
| 2019 | 0.40x | CN¥112.09 Million | CN¥280.49 Million | CN¥168.40 Million | ▼ -25.3% |
| 2018 | 0.53x | CN¥79.67 Million | CN¥149.00 Million | CN¥69.33 Million | ▼ -34.6% |
| 2017 | 0.82x | CN¥121.35 Million | CN¥148.32 Million | CN¥26.98 Million | ▼ -23.2% |
| 2016 | 1.07x | CN¥235.22 Million | CN¥220.72 Million | CN¥14.50 Million | — |